Test Directory

Test Code
5193
Test Name
Neurofibromatosis And Related Disorders NGS Panel
CPT Codes
81405, 81406, 81408, 81479
Expected Turnaround Time
Typically 2 to 4 weeks from receipt of a sample in the laboratory. All cases involving ongoing pregnancies will be expedited.
Clinical Utility
Genetic analysis to provide a molecular diagnosis of this disorder. Recommended for individuals with a personal and/or family history of this disorder to ensure appropriate treatment and establish recurrence risk for family members.
Specimen and Container Info

Non-Prenatal Specimens

Preferred/Alternate

Specimen Type

Containers

Volume

Preferred Specimen Type

Whole Blood

Lavender Top (EDTA)

3 mL

Alternate Specimen Type

Genomic DNA

1.5 mL Tube

3 µg (at a concentration of at least 30 ng/µl), preferably in TE solution.

Alternate Specimen Type

Fibroblasts

T-25 Flasks

2 confluent T-25 flasks, filled to capacity

Alternate Specimen Type

Saliva (Whole blood is recommended for CNV)

DNA Self-Collection Kit or Oragene Saliva Collection Kit for Young Children

Follow kit instructions (www.dnagenotek.com)

Prenatal Specimens

Either specimen type below is acceptable.

Specimen Type

Containers

Volume

Cultured cells

T-25 Flasks

2 confluent T-25 flasks derived from amnio or CVS samples.

Genomic DNA

1.5 mL Tube

3 µg (at a concentration of at least 30 ng/µl), preferably in TE solution.

NOTE: For specimens from outside of North America, the preferred specimen type is Genomic DNA. HNL Genomics does not recommend shipping whole blood or cultured cells from any location other than the United States, Canada, or Mexico.

Transport Instructions
  • Transport at room temperature within 24 hours.
  • If the specimen cannot be transported to the lab within 24 hours, refrigerate for up to 72 hours.
  • Do not freeze or expose to extreme temperatures, refrigerate for up to 72 hours if cannot be transported to lab within 24 hours. 
Stability Requirements

Room Temperature

24 hours

Refrigerated

72 hours

Causes for Rejection
  • Improperly labeled specimen (minimum of two patient identifiers)
  • Inappropriate specimen type
  • Incomplete or incorrect test request form
  • Insufficient volume
  • Specimen has leaked in transit
  • Specimen without a test order
Methodology
Next Generation Sequencing and Copy Number Variation Analysis
Performing Location
Genomics - Snowdrift
Alternate Names
  • NF1
  • NF2
Description

Neurofibromatosis type I (NF1) is a neurocutaneous and tumor predisposing disorder with an incidence at birth of about 1 in 3,000 individuals. It is characterized by café-au-lait spots, axillary and inguinal freckling, Lisch nodules in the eye and fibromatous tumors of the skin. NF1 is associated with increased risk for development of benign and malignant tumors.

Neurofibromatosis type 2 (NF2), the central type of NF, is a multiple neoplasia syndrome with the incidence of about 1 in 25,000 live births. The most common findings include bilateral vestibular schwannoma associated with tinnitus, hearing loss and balance dysfunction. Some individuals with NF2 may also develop brain meningiomas and schwannomas of the dorsal roots of the spinal cord, and very rarely astrocytomas. NF1 associated skin findings, café-au-lait spots and neurofibromata, are seen occasionally.

Mismatch repair cancer syndrome (MMRCS) is a rare childhood cancer syndrome with the following major tumor types: hematologic malignancies, brain/CNS tumors, colorectal tumors and multiple intestinal polyps, and other malignancies including embryonic tumors and rhabdomyosarcoma. Many individuals with MMRSC have café-au-lait spots similar to NF1. The skin lesions are often the first manifestation of MMRCS.

Legius syndrome is a genetically distinct disorder with a similar phenotype to NF1 including multiple café-au-lait spots and axillary freckling.

The neurofibromatosis and related disorders NGS panel consists of six genes: MLH1, MSH2, MSH6, NF1, NF2, SPRED1.

Gene

Disorder

MIM

Inheritance

MLH1

Mismatch repair cancer syndrome

276300

AR

MSH2

Mismatch repair cancer syndrome

276300

AR

MSH6

Mismatch repair cancer syndrome

276300

AR

NF1

Neurofibromatosis type 1

162200

AD

NF2

Neurofibromatosis type 2

101000

AD

SPRED1

Legius syndrome

611431

AD

Testing Schedule
Monday-Friday
Genes
MLH1, MSH2, MSH6, NF1, NF2, SPRED1
Disease Group
Neuromuscular, Skin